Dr.
A Conversation with Jenna Moyer
November 8, 2021
We are pleased to introduce our colleague Jenna Moyer, a Research Specialist on the EIPM organoid team.
We hope you enjoy learning more about her research interests and background!
Question: Can you please tell me about your work with organoids and how you first learned about this area of research?
EIPM Directors Memo November 2021
October 31, 2021
Dear Members of the Englander Institute,
It’s always a pleasure to share the important work and contributions of our colleagues, especially those who are just beginning their careers. Over the next several weeks we will feature interviews on the News page of our website with colleagues like Helen Kuo, a PhD Candidate mentored by myself and Dr. Laura Martin. I hope you enjoy learning more about their backgrounds and research interests.
EIPM, MCC & MoMA Save Summer for Dozens of Local Students
October 22, 2021
Many young people hoped the summer of 2021 would represent a return to normalcy in New York City. The continuing Covid-19 pandemic and Delta variant, however, upended many of those plans to find meaningful opportunities for personal, social, and educational growth during the summer months.
But not all summer plans were dashed. 48 high school and college students enjoyed a rich and rewarding six-week virtual summer program hosted by Weill Cornell Medicine’s (WCM) Englander Institute for Precision Medicine and the Meyer Cancer Center.
Recognizing Dr. Juan Miguel Mosquera
October 18, 2021
Dr. Juan Miguel Mosquera was only 17 years old when he started medical school. His interest in science drove him to pursue his career. Starting medical school in Colombia at an early age was challenging for Dr. Mosquera, but he stayed determined.
During this time, Dr. Mosquera’s senior classmate was traveling to Chicago for residency, and he was inspired. “After he explained the process to me, I thought ‘I can do this. It’s very difficult, but I can do it.’”
A Conversation with Helen Kuo
October 18, 2021
We are pleased to introduce our colleague Hui-Hsuan (Helen) Kuo, a Ph.D. Candidate in the Department of Pharmacology, who is being mentored by our Director Olivier Elemento, Ph.D. and our Ex Vivo Models Director M. Laura Martin, Ph.D.
We hope you enjoy learning more about her research interests and background!
Question: Can you please tell me about your work as a Ph.D. candidate in the Department of Pharmacology?
Fall 2021 EIPM Newsletter
October 5, 2021
October 2021
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our third quarterly newsletter of 2021, we hope you enjoy learning more about the important progress we’ve made since June.
A Conversation with Dr. Jason G. Mezey
September 30, 2021
We are pleased to introduce our newest EIPM Member, Dr. Jason G. Mezey.
Dr. Jason Mezey is a Principal Investigator in the Cornell University Department of Biological Statistics and Computational Biology, and a new Member of the Englander Institute for Precision Medicine.
We hope you enjoy learning more about his research interests and background.
Question: Please provide a brief bio and overview of your work.
Antibody-Producing B Cells May be “Predestined” for their Fates
September 23, 2021
The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine. The findings provide new insight into the inner workings of the immune system and may help understand how tissues develop and how certain cancers arise.
The study, published Sept. 23 in Nature Immunology, combined computational analyses with advanced molecular biology and genomic techniques to identify a protein called Oct2 as the key determinant of the B-cell humoral immune response.
Scientists Find a New Way to Reverse Immune Suppression in Tumors
September 20, 2021
Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian has uncovered a new way to counter this immunosuppressive effect.